Objective To evaluate whether the presence of cervical funneling or intra-amniotic debris identified in the second trimester is associated with a higher rate of preterm birth (PTB) (adjusted OR (aOR), 1.85 (95% CI, 2.78 (95% CI,, respectively), but not cervical funneling (aOR, 1.17 (95% CI, 1.45 (95% CI,, respectively). 
INTRODUCTION
Preterm birth (PTB) remains a major cause of morbidity and mortality worldwide. Not only is it responsible for approximately 50% of childhood blindness and one-third of cerebral palsy, but it has been implicated increasingly in adult morbidities, such as cardiovascular disease, in the offspring 1, 2 . Correspondingly, reduction in the rate of PTB has been a prominent public health goal and a focus of perinatal research.
Nevertheless, efforts at prevention have had limited success, and the frequency of PTB has increased over the past decades [3] [4] [5] . One prophylactic intervention that has shown efficacy for the prevention of recurrent PTB is the use of 17-alpha-hydroxyprogesterone caproate (17-P) although, in women with other risk factors, such as multiple gestation and short cervical length (CL), 17-P has not shown benefit [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Conversely, two randomized trials have shown a lower rate of PTB among women with a short cervix treated with vaginal progesterone and, as such, several investigators have advocated routine mid-trimester CL screening [17] [18] [19] [20] . When performing transvaginal ultrasound for CL measurement, additional findings may be noted that may have value in determining the risk for PTB. Two such findings in particular that have received attention are the presence of intra-amniotic 'debris' (or 'sludge' ) at the internal os, and cervical funneling. Some studies have shown an association between these findings and PTB while others have not [21] [22] [23] [24] [25] [26] [27] . The limitations of previous studies include small sample size, a combination of low-and high-risk patients and a lack of standardized sonographic evaluation.
A randomized placebo-controlled trial of 17-P in asymptomatic nulliparous women with a midtrimester CL less than 30 mm (i.e. below the 10 th percentile when measured in the midtrimester) was completed at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network, in which it was found that treatment did not reduce PTB 11 . In this trial, the transvaginal ultrasound examination included a standardized evaluation for intra-amniotic debris and cervical funneling. The objective of this secondary analysis of data from this trial was to evaluate whether the presence of cervical funneling or intra-amniotic debris is associated with a higher rate of PTB.
PATIENTS AND METHODS
This study is a secondary analysis of a multicenter trial in women between 16 and 22 weeks' gestation with a singleton pregnancy and a CL less than 30 mm on transvaginal ultrasound who were randomized to weekly intramuscular injections of either 17-P or placebo 11 . From April 2007 to May 2011, the 14 centers of the NICHD MFMU Network participated in this randomized double-blind placebo-controlled trial. The study was approved by the institutional review board at each clinical site and at the data coordinating center, and all women provided written informed consent prior to enrollment.
The full methods and results of the primary study have been reported previously 11 . Briefly, women were eligible for participation if they were nulliparous with a viable singleton gestation and had a CL of less than 30 mm at 16 + 0 to 22 + 3 weeks' gestation. All women underwent transvaginal ultrasound by trained and certified sonographers for evaluation of CL, cervical funneling (defined as protrusion of the amniotic membranes ≥ 3 mm into the internal os, as measured from the midpoint of the funnel to the midpoint of the internal os), and intra-amniotic debris adjacent to the cervix (defined as areas of increased echodensity within the amniotic cavity that are variable in shape and size, and that move or float away in response to pressure on the abdomen or probe). A representative image of debris is presented in Figure 1 . No changes in management were mandated by the study protocol based on the presence of funneling or debris. Women were excluded if they had any of the following: prior selective fetal reduction to a singleton gestation; sonographic evidence of an additional fetal pole at 12 weeks' gestation or later; progestogen treatment after 14 + 6 weeks; vaginal bleeding heavier than spotting after 15 + 6 weeks; amniotic membranes prolapsing beyond the external os; premature rupture of membranes; a known major fetal anomaly or aneuploidy; current or planned cervical cerclage; a known Müllerian abnormality; a contraindication to intramuscular injections; a maternal medical condition that increases the probability of PTB; prior cervical surgery; or a plan for indicated PTB. Eligible women were assigned randomly to receive weekly intramuscular injections of identical-appearing 17-P (250 mg) or placebo (castor oil).
On primary analysis of the randomized trial, the frequencies of PTB and adverse pregnancy outcome did not differ between the 17-P and placebo groups, and therefore the two groups were combined in the current analysis. All women with either cervical funneling or intra-amniotic debris were identified. Demographic and obstetric characteristics were compared between women who had either of these two findings and those who had neither. The primary outcome was the frequency of PTB before 37 weeks, which was compared using univariable analysis between women with and those without cervical funneling and between those with and those without intra-amniotic debris. Secondary analysis using gestational age thresholds for PTB before 34 + 0 weeks and before 32 + 0 weeks was also performed. Continuous variables were compared using the Wilcoxon rank-sum test, and categorical variables were compared using the chi-square or Fisher's exact test, as appropriate.
A series of multivariable analyses using logistic regression were performed with estimation of odds ratios (ORs) and 95% CI, adjusted for factors potentially confounding the relationship of cervical funneling or intra-amniotic debris with PTB. All multivariable models included treatment group (i.e. 17-P). Other covariates were included if their association on univariable analysis had a P-value of ≤ 0.05. Neither maternal race/ethnicity nor gestational age at delivery was included as a factor in multivariable analyses, given their potential for introducing collider bias 28 . Selected perinatal outcomes were compared based on sonographic findings that remained significant on multivariable analysis. These outcomes included a composite of serious adverse outcomes, which was defined as occurrence of any of the following: respiratory distress syndrome, bronchopulmonary dysplasia, early-onset sepsis, Stage II or III necrotizing enterocolitis, Grade III or IV intraventricular hemorrhage, periventricular leukomalacia, Stage III or higher retinopathy of prematurity and fetal or neonatal death.
All tests were two-tailed, and P < 0.05 was used to indicate statistical significance. Analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Of the 657 patients randomized, 112 (17%) had cervical funneling only, 33 (5%) had intra-amniotic debris only, and 45 (7%) had both on the second-trimester ultrasound examination that qualified participants for the randomized trial. Women with either of these sonographic findings were older, were less likely to be non-Hispanic white, had a higher prepregnancy body mass index, were screened at a later gestational age and had a shorter CL than those without (Table 1) .
Preterm birth before 37 weeks was more likely in women with cervical funneling (OR 2.23 (95% CI, 1.51-3.29)) and those with intra-amniotic debris (OR 1.74 (95% CI, 1.05-2.88)). Results were similar for PTB *Adjusted for treatment with 17-alpha-hydroxyprogesterone caproate (17-P). †Adjusted for treatment with 17-P, cervical length at screening and estimated GA at screening ultrasound. ‡Adjusted for treatment with 17-P, cervical length at screening, estimated GA at screening ultrasound and maternal age and body mass index. aOR, adjusted odds ratio.
of cervical funneling persisted after adjustment for 17-P administration, but not after further adjustment for CL and gestational age at screening. After this further adjustment, only the presence of intra-amniotic debris remained associated with PTB before 34 or before 32 weeks' gestation (Table 3) . The association of perinatal outcome with intraamniotic debris was assessed. The frequency of composite adverse perinatal outcome was higher in women with intra-amniotic debris (Table 4) . However, the association of the composite adverse outcome with the presence of debris was most probably due to the association of both with PTB, as the association lost significance after adjustment for 17-P, CL at screening and gestational age at screening (OR 1.96 (95% CI, 0.95-4.05)).
DISCUSSION
In this study, we evaluated the risk of PTB in asymptomatic nulliparous women with a midtrimester CL of less than 30 mm in the presence of cervical funneling and/or intra-amniotic debris on second-trimester transvaginal ultrasound. Our data reveal that cervical funneling is not associated independently with PTB. However, intra-amniotic debris remained associated with PTB before 34 and before 32 weeks, even after controlling for potential confounding factors. Moreover, the magnitude of the association between intra-amniotic debris and PTB was greater at earlier gestational age thresholds (Table 3) . It has been postulated that the presence of intra-amniotic debris may be associated with intra-amniotic infection 29 . If so, the increased risk of PTB associated with intra-amniotic debris, which is greater than that conveyed by CL alone, may be explained at least partly by the presence of underlying intra-amniotic infection.
These findings support and extend those of previous investigations. For example, cervical funneling has been associated with gestational age at birth on univariable analysis, but not on multivariable analysis when CL was taken into account 27 . Similarly, the presence of intra-amniotic debris has been associated with gestational age at delivery, although the association with adverse perinatal outcome has not been well explored previously 23, 24 . Furthermore, the association of debris with PTB has been documented previously in a population with a relatively small number of women with a short cervix 21, 23 . Consequently, it has not been well established if this association is independent of CL and exists specifically in women who are already at increased risk for PTB owing to a short cervix.
The present analysis was performed using data from a large population of women whose CL in the midtrimester was below the 10 th percentile. Moreover, the population was geographically and demographically diverse, and all sonographic cervical assessments were performed by trained and certified sonographers. These characteristics strengthen the validity and generalizability of the conclusions to other nulliparous women with a CL below the 10 th percentile. Nevertheless, because the study population was not a general obstetric population, we cannot know whether the associations are similar among women with a CL above the 10 th percentile or parous women regardless of CL. Also, it should be noted that the primary outcome of the randomized trial was PTB before 37 weeks, while the gestational age thresholds that were associated significantly with intra-amniotic debris on multivariable analysis were 34 and 32 weeks.
At present, many nulliparous women undergoing midtrimester ultrasound assessment will have their CL measured transvaginally. Based on our findings, those with midtrimester CL less than 30 mm are not at additional risk for PTB, over and above that conveyed by CL alone, based on the presence of cervical funneling. Intra-amniotic debris, however, is associated with a further increase in the risk of PTB among women with midtrimester CL below the 10 th percentile, and further investigation should be carried out to determine whether particular prophylactic interventions are more effective in this population.
